Terapias de triple combinación de anticuerpos

The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LOGRONIO, Kathryn, LIANG, Spencer, AZULAY, Meir, CHAN, Christopher, KOTTURI, Maya, MACHLENKIN, Arthur, ALTEBER, Zoya, DESAI, Radhika, OPHIR, Eran, LEUNG, Ling, KUMAR, Sandeep, WHELAN, Sarah
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is directed to triple combination therapies with anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies.